10 /100
LOW RISK
Score updated May 29, 2026

ALNY — Alnylam Pharmaceuticals, Inc. Dilution Risk Tracker

Track ALNY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ALNY — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ALNY.
🔔 Track ALNY — Get forecast alerts →

💹 Market Data

Market Cap$40.73B
Shares Outstanding133.51M
Float132.95M
Cash$3.01B
Debt$2.97B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 0.8% shares (2025Q4 vs prior)
848 institutional holders · 140.64M shares
#1 Capital World Investors 16.30M shares
#2 FMR LLC 15.90M shares
#3 VANGUARD GROUP INC 13.55M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest4.77M
Days to Cover4.0
% of Float3.6%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Jul 13, 2005
3 FORM3 Apr 07, 2026
4 INSIDER TRANSACTION Mar 06, 2026
4 INSIDER TRANSACTION Mar 04, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track ALNY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ALNY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ALNY
📊 ALNY FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ALNY Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.